Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05046600 · ClinicalTrials.gov registry record
Registry of Arthrex Hand and Wrist Products
A clinical trial of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction, sponsored by Arthrex.
- Recruiting
- Registry status
- 650
- Enrollment target
- 5
- Study locations
NCT05046600: Recruiting study of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction, sponsored by Arthrex.
NCT05046600 is a study of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction that is actively recruiting participants, run by Arthrex. The registered enrollment target is 650 participants. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05046600, a study of Arthrodesis and Ulnar/Radial Collateral Ligament Reconstruction, is actively recruiting participants, sponsored by Arthrex.
- RECRUITING
- Registry status
- 650 participants
- Enrollment target
- 5
- Study locations
Study Summary
A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products
Primary Outcome
Patient reported pain scale 0-10 point scale (0 min,10 max)
Conditions Studied
Interventions
- DEVICE Products listed in cohort description
Study Locations (5)
Arizona
- MORE Foundation - Phoenix
- Banner Health - Tuscon
Iowa
- University of Iowa - Iowa City
North Carolina
- Duke University - Durham
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2025-12-01 |
What NCT05046600 shows while recruiting
NCT05046600 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap.
The record links to 10 conditions, with Arthrodesis appearing as the primary indexed condition, and to 1 intervention - of which Products listed in cohort description is the first listed.
NCT05046600 lists 5 locations in 4 states (Arizona, Iowa, North Carolina).
Frequently Asked Questions
What is clinical trial NCT05046600 about?
NCT05046600 is a clinical study titled "Registry of Arthrex Hand and Wrist Products". A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products
What is the current status of trial NCT05046600?
This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2021-07-20. Estimated completion is 2025-12-01.
What conditions does trial NCT05046600 study?
This clinical trial studies the following conditions: Arthrodesis, Ulnar/Radial Collateral Ligament Reconstruction, Ligament Repair or Reconstruction, Small Bone Fragments and Arthrodesis, Scapholunate Ligament Reconstruction.
What interventions are being tested in trial NCT05046600?
The interventions under investigation include: Products listed in cohort description (DEVICE).
Who is sponsoring clinical trial NCT05046600?
This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05046600 being conducted?
This trial has 5 study locations across Arizona, Iowa, North Carolina, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthrodesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05253235 · 650 participants · NA
Health and Resilience Projects: Foundations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI